<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-22T20:21:08Z</responseDate><request verb="GetRecord" identifier="oai:uwspace.uwaterloo.ca:10012/20955" metadataPrefix="dim">https://dspacemainprd01.lib.uwaterloo.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:uwspace.uwaterloo.ca:10012/20955</identifier><datestamp>2025-03-26T23:38:38Z</datestamp><setSpec>com_10012_9860</setSpec><setSpec>com_10012_1</setSpec><setSpec>col_10012_9864</setSpec><setSpec>col_10012_6</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Hammond, David</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">D&amp;apos;Mello, Kimberly</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2024-09-04T12:26:20Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2024-09-04T12:26:20Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2024-09-04</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="submitted">2024-07-24</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://hdl.handle.net/10012/20955</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract">Background: E-cigarettes are a popular method of smoking cessation assistance. However, few studies have examined whether e-cigarettes serve as a substitute for other effective smoking cessation assistance, including how population-level changes in the use of e-cigarettes for smoking cessation compare to changes in the use of nicotine replacement therapy (NRT), prescription pharmacological therapies, and other smoking cessation methods.

Objectives: To examine changes in the types of cessation assistance used by people trying to quit smoking over time, including: 1) the use of e-cigarettes in a quit attempt and 2) the use of other effective methods of cessation assistance.

Methods: The study protocol has been preregistered (https://osf.io/jpnqc). Data are from the 2016, 2018, and 2020 Waves of the ITC Four Country Smoking and Vaping Survey. Respondents were recruited by commercial panel firms in each country who were ≥ 18 years of age and, who currently smoke, recently quit smoking, and/or currently vape. Analyses examined the use of cessation assistance among the 14,551 observations from participants with an attempt to quit smoking in the past 12-months since survey date (CA=4,880; US=2,917; EN= 4,846; AU=1,898). Repeat cross-sectional analyses were conducted using generalized estimating equations stratified by country. 

Results: Across all countries, e-cigarettes (29.9%) and nicotine replacement therapies (NRT; 29.8%) were the most commonly reported categories of cessation assistance used in a previous quit attempt, followed by self–help services (17.8%), and prescription pharmacological therapies (12.6%). Overall, more than half (59.4%) of respondents used ‘any’ form of effective cessation assistance (including e-cigarettes). E-cigarette use increased in Australia from 2016 (11.1%) to 2020 (25.1%; OR=2.29, 95% CI=1.37-3.82, p=.002). In England, e-cigarette use increased from 2016 (37.1%) to 2018 (46.7%; OR=1.40, 95% CI=1.13-1.73, p=.002), and had no changes over time in Canada or the US. Use of other effective cessation methods (with and without e-cigarettes) had no changes over time in all countries, excluding Canada. In Canada, use of ‘any’ form of effective cessation assistance (including e-cigarettes) decreased from 2016 (64.0%) to 2020 (58.9%; OR=0.75, 95% CI=0.61-0.93, p=.010).

Conclusion: Overall, there were strikingly similar rates of effective cessation assistance used across all four countries, despite differences in e-cigarette use and regulatory environments. While e-cigarettes are a popular choice of cessation method, there was little evidence that trends in use of e-cigarettes contributed to changes in the use of ‘any’ effective form of cessation assistance. The extent of ‘substitution’ between individual quit methods at the population-level was not directly assessed in this study; however, there was some evidence consistent with substitution for e-cigarettes and use of prescription therapies such that, the use of prescription therapies increased in England as the use of e-cigarettes as a quit method decreased, with the inverse trend in Australia; and little to no changes in the US and Canada.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso">en</dim:field>
   <dim:field mdschema="dc" element="publisher" lang="en">University of Waterloo</dim:field>
   <dim:field mdschema="dc" element="subject">vaping</dim:field>
   <dim:field mdschema="dc" element="subject">smoking</dim:field>
   <dim:field mdschema="dc" element="subject">smoking cessation</dim:field>
   <dim:field mdschema="dc" element="subject">e-cigarettes</dim:field>
   <dim:field mdschema="dc" element="title">The Use of Vaping Products in Attempts to Stop Smoking: Trends Over Time and Possible Substitution for Other Smoking Cessation Aids in Canada, the United States, England, and Australia</dim:field>
   <dim:field mdschema="dc" element="type">Master Thesis</dim:field>
   <dim:field mdschema="dc" element="pending">false</dim:field>
   <dim:field mdschema="uws-etd" element="degree" qualifier="department">School of Public Health Sciences</dim:field>
   <dim:field mdschema="uws-etd" element="degree" qualifier="discipline">Public Health and Health Systems</dim:field>
   <dim:field mdschema="uws-etd" element="degree" qualifier="grantor" lang="en">University of Waterloo</dim:field>
   <dim:field mdschema="uws-etd" element="degree">Master of Science</dim:field>
   <dim:field mdschema="uws-etd" element="embargo" qualifier="terms">0</dim:field>
   <dim:field mdschema="uws" element="comment" qualifier="hidden">attached revised thesis per submission rejection instructions</dim:field>
   <dim:field mdschema="uws" element="contributor" qualifier="advisor">Hammond, David</dim:field>
   <dim:field mdschema="uws" element="contributor" qualifier="affiliation1">Faculty of Health</dim:field>
   <dim:field mdschema="uws" element="published" qualifier="city" lang="en">Waterloo</dim:field>
   <dim:field mdschema="uws" element="published" qualifier="country" lang="en">Canada</dim:field>
   <dim:field mdschema="uws" element="published" qualifier="province" lang="en">Ontario</dim:field>
   <dim:field mdschema="uws" element="typeOfResource" lang="en">Text</dim:field>
   <dim:field mdschema="uws" element="peerReviewStatus" lang="en">Unreviewed</dim:field>
   <dim:field mdschema="uws" element="scholarLevel" lang="en">Graduate</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>